Stay updated with breaking news from Prevention Framework. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The U.S. Food and Drug Administration on Monday approved a second nasal spray for reversing an opioid overdose. To be sold as Opvee, the spray contains the medication nalmefene hydrochloride.
The U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known or suspected opioid overdose in adults and pediatric patients 12 years of age and older
/PRNewswire/ -- Today, the U.S. Food and Drug Administration approved Opvee, the first nalmefene hydrochloride nasal spray for the emergency treatment of known...
The ECOWAS Commission is holding a Monitoring and Evaluation (M&E) capacity building Workshop to enhance the quality of internal results assessments, learning, as well as the reporting processes of its programme implementation. The Three-Day Workshop which began on the 26th of April, 2023 in Abuja, Nigeria, is also meant to…
The ECOWAS Commission is holding a Monitoring and Evaluation (M&E) capacity building Workshop to enhance the quality of internal results assessments, learning, as well as the reporting processes of its programme implementation. The Three-Day Workshop which began on the 26th of April, 2023 in Abuja, Nigeria is also meant to…